Patent ID: 8309121

Claim:
A composition comprising lipid nanocapsules, said lipid nanocapsules comprising: (a) an oily inner phase consisting of diisopropyl adipate and ivermectin solubilized in said diisopropyl adipate; and (b) a surfactant comprising soybean and/or egg lecithin(s) having a hydrogenated phosphatidylcholine content of greater than 70% by weight, said surfactant being lipophilic, solid at room temperature and coating said oily inner phase; said lipid nanocapsules being dispersed in a continuous hydrophilic phase; said composition being devoid of any surfactant(s) other than said lecithin(s); said composition being devoid of any organic solvent(s) other than said diisopropyl adipate; said composition being devoid of propenetrating agents; said composition being physically stable at 4° C., ambient temperature and 40° C., for a period of two months; said ivermectin being chemically stable in said composition at 4° C., ambient temperature and 40° C., for a period of three months.